BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38205942)

  • 1. Association of area-level mortgage denial and guideline-concordant non-small-cell lung cancer care and outcomes in the United States.
    Fan Q; Hussaini SMQ; Barrow LCJ; Feliciano JL; Pollack CE; Yabroff KR; Nogueira L
    Cancer Med; 2024 Feb; 13(3):e6921. PubMed ID: 38205942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
    Nadpara P; Madhavan SS; Tworek C
    Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Historical Housing Discrimination and Colon Cancer Treatment and Outcomes in the United States.
    Hussaini SMQ; Fan Q; Barrow LCJ; Yabroff KR; Pollack CE; Nogueira LM
    JCO Oncol Pract; 2024 May; 20(5):678-687. PubMed ID: 38320228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
    Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
    Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
    [No Abstract]   [Full Text] [Related]  

  • 5. Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States.
    Nadpara PA; Madhavan SS; Tworek C; Sambamoorthi U; Hendryx M; Almubarak M
    J Geriatr Oncol; 2015 Mar; 6(2):101-10. PubMed ID: 25604094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
    Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
    Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
    Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
    Stokes SM; Massarweh NN; Stringham JR; Varghese TK
    Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do HIV-infected non-small cell lung cancer patients receive guidance-concordant care?
    Lee JY; Moore PC; Steliga MA
    Med Care; 2013 Dec; 51(12):1063-8. PubMed ID: 24220684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
    Wu SY; Lazar AA; Gubens MA; Blakely CM; Gottschalk AR; Jablons DM; Jahan TM; Wang VEH; Dunbar TL; Wong ML; Chan JW; Guthrie W; Belkora J; Yom SS
    JAMA Netw Open; 2020 Sep; 3(9):e209750. PubMed ID: 32997124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
    Nicoli CD; Sprague BL; Anker CJ; Lester-Coll NH
    Am J Clin Oncol; 2019 Jul; 42(7):607-614. PubMed ID: 31232724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Receipt of Guideline-Concordant Lung Cancer Treatment and Individual- and Area-Level Factors: A Spatio-Temporal Analysis.
    Wah W; Stirling RG; Ahern S; Earnest A
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2669-2679. PubMed ID: 32948632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database.
    Gupta A; Omeogu C; Islam JY; Joshi A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
    Sci Rep; 2023 May; 13(1):8190. PubMed ID: 37210410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
    Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race and sex differences in the receipt of timely and appropriate lung cancer treatment.
    Shugarman LR; Mack K; Sorbero ME; Tian H; Jain AK; Ashwood JS; Asch SM
    Med Care; 2009 Jul; 47(7):774-81. PubMed ID: 19536007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
    Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
    Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer in the United States.
    Nogueira LM; May FP; Yabroff KR; Siegel RL
    J Clin Oncol; 2024 Apr; 42(12):1368-1377. PubMed ID: 37939323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer.
    Ray MA; Faris NR; Derrick A; Smeltzer MP; Osarogiagbon RU
    Chest; 2020 Aug; 158(2):787-796. PubMed ID: 32387525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer.
    Casebeer A; Antol DD; DeClue RW; Hopson S; Li Y; Khoury R; Michael T; Sehman M; Parikh A; Stemkowski S; Bunce M
    J Manag Care Spec Pharm; 2018 Jun; 24(6):554-564. PubMed ID: 29799325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.